Literature DB >> 10725436

Ectromelia virus virulence factor p28 acts upstream of caspase-3 in response to UV light-induced apoptosis.

D J Brick1, R D Burke, A A Minkley, C Upton.   

Abstract

Ectromelia virus (EV) virulence factor p28 (EVp28) is a member of a family of poxvirus proteins that are defined largely by the presence of a C-terminal RING finger motif and localization to virus factories within the cytoplasm of infected cells. Previously, overexpression of the Shope fibroma virus (SFV) homologue, N1R, in vaccinia virus (VV)-infected BGMK cells was found to inhibit virus-induced apoptosis. Here, we report that both EVp28 and overexpression of SFV N1R in poxvirus-infected HeLa cells protect specifically from UV light-induced apoptosis, but not from apoptosis induced by Fas or TNF. Further, we report that both VV and EV protect from apoptosis induced by UV, Fas and TNF. Immunoblot analysis indicates that EVp28 acts upstream of caspase-3, blocking activation of the protease in response to UV irradiation. Although no difference was found in replication of an EVp28(-) mutant virus, which expresses a truncated p28 protein lacking the RING motif, compared to EV wild-type in HeLa cells, UV irradiation of infected HeLa cells reduced the replication of the EV mutant compared with wild-type EV.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10725436     DOI: 10.1099/0022-1317-81-4-1087

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  15 in total

1.  N1L is an ectromelia virus virulence factor and essential for in vivo spread upon respiratory infection.

Authors:  Meike S Gratz; Yasemin Suezer; Melanie Kremer; Asisa Volz; Monir Majzoub; Kay-Martin Hanschmann; Ulrich Kalinke; Astrid Schwantes; Gerd Sutter
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

2.  Functional analysis of the inhibitor of apoptosis (iap) gene carried by the entomopoxvirus of Amsacta moorei.

Authors:  Qianjun Li; Peter Liston; Richard W Moyer
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

3.  The poxviral RING protein p28 is a ubiquitin ligase that targets ubiquitin to viral replication factories.

Authors:  Bianca T Hovey Nerenberg; John Taylor; Eric Bartee; Kristine Gouveia; Michele Barry; Klaus Früh
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  Mutational analysis of vaccinia virus E3 protein: the biological functions do not correlate with its biochemical capacity to bind double-stranded RNA.

Authors:  Kevin J Dueck; YuanShen Sandy Hu; Peter Chen; Yvon Deschambault; Jocelyn Lee; Jessie Varga; Jingxin Cao
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

5.  A novel Bcl-2-like inhibitor of apoptosis is encoded by the parapoxvirus ORF virus.

Authors:  Dana Westphal; Elizabeth C Ledgerwood; Merilyn H Hibma; Stephen B Fleming; Ellena M Whelan; Andrew A Mercer
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

Review 6.  Poxviruses and the evolution of host range and virulence.

Authors:  Sherry L Haller; Chen Peng; Grant McFadden; Stefan Rothenburg
Journal:  Infect Genet Evol       Date:  2013-10-24       Impact factor: 3.342

7.  Cellular source of the poxviral N1R/p28 gene family.

Authors:  Robert D Nicholls; Todd A Gray
Journal:  Virus Genes       Date:  2004-12       Impact factor: 2.198

8.  Poxvirus exploitation of the ubiquitin-proteasome system.

Authors:  Michele Barry; Nicholas Van Buuren; Kristin Burles; Kelly Mottet; Qian Wang; Alastair Teale
Journal:  Viruses       Date:  2010-10-19       Impact factor: 5.818

9.  Caspase-dependent inhibition of mousepox replication by gzmB.

Authors:  Julián Pardo; Eva María Gálvez; Aulikki Koskinen; Markus M Simon; Mario Lobigs; Matthias Regner; Arno Müllbacher
Journal:  PLoS One       Date:  2009-10-19       Impact factor: 3.240

10.  Inhibition of type 1 cytokine-mediated inflammation by a soluble CD30 homologue encoded by ectromelia (mousepox) virus.

Authors:  Margarida Saraiva; Philip Smith; Padraic G Fallon; Antonio Alcami
Journal:  J Exp Med       Date:  2002-09-16       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.